CompanyNewsHQ
THOUSAND OAKS, Calif., June 15, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with Allan Avendaño, makeup artist to
Read moreTHOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Read moreTHOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today presented data on overall survival, a secondary endpoint, from
Read moreTHOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced updated results for investigational bemarituzumab in combination with chemotherapy
Read moreTHOUSAND OAKS, Calif., June 1, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) will host a webcast call for the investment community
Read moreAgreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells
Read moreTHOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET
Read moreTHOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration
Read moreTHOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit
Read moreTHOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that new data from its expanding oncology
Read moreTHOUSAND OAKS, Calif., May 13, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced detailed results for tezepelumab, a potential
Read moreTHOUSAND OAKS, Calif., May 11, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the presentation of four cardiovascular research abstracts, including
Read moreTHOUSAND OAKS, Calif., May 10, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application
Read moreTHOUSAND OAKS, Calif., May 6, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2021 Bank of America Merrill Lynch Virtual Healthcare
Read moreTHOUSAND OAKS, Calif., May 5, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for
Read moreTHOUSAND OAKS, Calif., April 28, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it agreed last night with the FDA’s proposed post-marketing requirement
Read moreTHOUSAND OAKS, Calif., April 27, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2021.
Read moreTHOUSAND OAKS, Calif., April 23, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) improved measures of disease severity in adults
Read moreTHOUSAND OAKS, Calif., April 22, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results
Read moreTHOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) granted
Read moreTHOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™, a program
Read moreTHOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced
Read moreTHOUSAND OAKS, Calif. and SEATTLE, March 30, 2021 /PRNewswire/ — Amgen Inc. (NASDAQ:AMGN) and Rodeo Therapeutics Corporation (Rodeo) today announced an
Read moreTHOUSAND OAKS, Calif., March 11, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the virtual Oppenheimer 31st Annual Healthcare Conference
Read moreTHOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ:
Read more